Oberkochen, Germany and Pleasanton, CA, USA – June 13th, 2013 – ZEISS, the international leader in the fields of optics and optoelectronics today announced the planned acquisition of the US-based Xradia, Inc. Xradia is a medium-size company providing innovative 3D X-ray microscopes for industrial and academic research applications. The closing of the transaction is subject to the fulfillment of customary closing conditions including a required filing with the U.S. competition authorities. After closing, Xradia, Inc. will operate under the new name Carl Zeiss X-ray Microscopy, Inc.
24.04.2013 – Calgary, Alberta and Zürich, Switzerland – April 23, 2013 – Acceleware Ltd. (TSXV:AXE) today announced that SCANCO Medical AG, Zürich, Switzerland has agreed to acquire a perpetual, non-exclusive license for Acceleware’s AxRecon™ source code. AxRecon is an advanced GPU solution for accelerated image reconstruction on Computed Tomography (CT) scanners. Under the license acquisition terms, SCANCO will become the exclusive provider of AxRecon to the medical imaging market. SCANCO intends to continue advancing the product and expand its availability to a wider range of CT scanners.
10.09.2012 – Scanco Medical AG and b-cube AG are pleased to announce that the two companies have entered negotiations for Scanco Medical to acquire b-cube in mutual agreement. Scanco Medical (www.scanco.ch) is a company that specializes in the development of state-of-the-art micro-computed tomography systems and b-cube (www.b-cube.ch) is an innovative service provider focused on high-resolution imaging and 3D analysis of porous and composite structures, such as bone, biomaterials and implants. With this acquisition, the two companies expect that b-cube’s products can be further enhanced with higher efficiency and a significant increase in the market share.
NORTHRIDGE, CA— October 4, 2012—Judge Victoria Kaufman of the U.S.Bankruptcy Court for the Central District of California (San Fernando ValleyDivision) approved Gamma Medica Inc.’s $1.5 million debtor in-possession (“DIP”) financing on a final basis yesterday, as part of its Chapter 11 restructuring. This DIP financing order provides the molecular breast imaging (MBI) manufacturer with sufficient financing to pursue a reorganization or asset sale. “Gamma Medica’s LumaGEM® Molecular Breast Imaging System is already in the market and is very promising,” said recently named CEO Jim Calandra. “We also have industry leading preclinical imaging products. We plan on being sure our tools are in the hands of researchers and radiologists working in women’s imaging.”
Bruker Announces Acquisition of SkyScan, a Leading Provider of Micro-CT Systems for 3D X-Ray Imaging in Materials Research and Preclinical Studies.
ANTWERP, Belgium – April 2, 2012 – Bruker Corporation today announced that it has acquired all of the shares of SkyScan N.V., a scientific instruments company located near Antwerp, Belgium. Financial details were not disclosed. For the remainder for 2012, the acquisition of SkyScan is expected to add approximately $13 million to Bruker’s revenue and to be accretive to EPS by about $0.01. SkyScan’s revenue is derived approximately 50% from materials science and 50% from life science and preclinical imaging applications.
Find out who’s doing what in microCT, or let the world know what you do!
There is now a dedicated microCT world community map page on the blog! Check it out to navigate through the microCT community. You’ll find scanner manufacturers, service providers, research labs, and more. Please, consider this as a living document that will take some time to be populated. If you are a professional who wants to be listed on the map, drop a comment on the dedicated page. Only companies / institutes / individuals who explicitly ask to be listed on the map will be included.
I hope you’ll find the map a useful tool and would be happy to receive any suggestion you may have.
MicroCT is a very powerful technology, though it does not come for free.
When running a project, either in academic or industry settings, we are always faced with budget restrictions. The challenge is getting the most out of the money we invest.
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company has completed its acquisition of Caliper Life Sciences, Inc. (NASDAQ: CALP), a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets. In September, PerkinElmer announced its intent to acquire Caliper for $10.50 per share, for a total net purchase price of approximately $600 million in cash.
Read the full article on Perkin Elmer’s website
WALTHAM, Mass.–(BUSINESS WIRE)– PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc. (NASDAQ: CALP), a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for $10.50 per share, for a total net purchase price of approximately $600 million in cash.
Maybe it is not as common and cheap as buying a microwave oven, but probably there are some of you who have thought about purchasing a microCT scanner, right?
Your questions: “Who are the scanner manufacturers?”, “Should I buy a scanner?”, “What scanner ?”. This post will point you towards the information you need to make up your mind.
At the end the decision whether the investment is worthwhile depends on many things. What do you want to use microCT for? How often? Do you know how to operate a scanner? Do you have the right resources? And many more….